GLP-1/GLP-2 dual agonist (Aoda Biotechnology)

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameGLP-1/GLP-2 dual agonist (Aoda Biotechnology)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucagon-like peptide 2 receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon-like peptide 2 receptor
Therapy Area/IndicationsCognition DisordersDyspepsiaObesity +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Aoda Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Aoda Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCognition DisordersDyspepsiaObesity +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A